Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 26

Results For "Cancer"

1027 News Found

Manipal Hospital Delhi opens advanced cancer care centre
Hospitals | December 23, 2021

Manipal Hospital Delhi opens advanced cancer care centre

The hospital has recently launched Radionuclide therapy


Trastuzumab Deruxtecan supplemental New Drug Application for breast cancer submitted in Japan
Biotech | December 14, 2021

Trastuzumab Deruxtecan supplemental New Drug Application for breast cancer submitted in Japan

In Japan, breast cancer is the most common cancer in women, with approximately 92,000 cases of breast cancer diagnosed in 2020


Samsung Biologics expands tie-up with AstraZeneca to include cancer therapy
Biotech | December 14, 2021

Samsung Biologics expands tie-up with AstraZeneca to include cancer therapy

The company will manufacture a cancer immunotherapy product from 2022


Oncologists call for adoption of tech innovations to treat cancer
Events | December 07, 2021

Oncologists call for adoption of tech innovations to treat cancer

The event was organized jointly by Oncology Forum and Fortis Cancer Institute, Delhi NCR


U.S. FDA approves Cytalux injection for identifying ovarian cancer during surgery
Drug Approval | November 30, 2021

U.S. FDA approves Cytalux injection for identifying ovarian cancer during surgery

It is the first targeted fluorescent imaging agent that illuminates ovarian cancer intraoperatively, enabling the detection of more cancer for removal


Fortis Escorts Faridabad introduces Cryo technique to treat lung cancer
Hospitals | November 24, 2021

Fortis Escorts Faridabad introduces Cryo technique to treat lung cancer

Cryo-technology helps in early diagnosis and palliative care in later stages of cancer


CStone and Jiangsu Hengrui sign exclusive licensing agreement for cancer drugs in China
Biotech | November 22, 2021

CStone and Jiangsu Hengrui sign exclusive licensing agreement for cancer drugs in China

CStone granted the exclusive rights to Hengrui for research, development, registration, manufacturing, and commercialization of anti-CTLA-4 mAb CS1002 in the Greater China region


Merck showcases potential for several cancers, MS and lupus
News | November 22, 2021

Merck showcases potential for several cancers, MS and lupus

Five potential first-in-class assets aimed at delivering significant long-term growth. Over 14 clinical development programs underway across portfolio and 11 new studies to start in 2022 across early- and late-stage pipeline


U.S. FDA grants breakthrough designation to Datar’s blood test to detect breast cancer
Drug Approval | November 20, 2021

U.S. FDA grants breakthrough designation to Datar’s blood test to detect breast cancer

It is the first blood test able to detect early-stage Breast Cancer with high accuracy in women above the age of 40 years


BGS Gleneagles Global hospital opens women’s cancer care centre
Hospitals | November 15, 2021

BGS Gleneagles Global hospital opens women’s cancer care centre

Early detection of breast cancer increases survival rate by 95 per cent